Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
Pablo García‐Pavía(Universidad Francisco de Vitoria), Bonnie Ky(Virginia Commonwealth University), Zoltàn Arany(Cardiovascular Institute Hospital), A. John Baksi(Royal Brompton & Harefield NHS Foundation Trust), Alicja Wilk(Royal Brompton & Harefield NHS Foundation Trust), Risha Govind(Royal Brompton & Harefield NHS Foundation Trust), Josep Lupón(Universitat Autònoma de Barcelona), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Alfredo Bardajı́(Institut de Recerca Biomèdica Catalunya Sud), Jonathan G. Seidman(Harvard University), Paul J.R. Barton(Guy's and St Thomas' NHS Foundation Trust), Parth Patel(Brigham and Women's Hospital), José Manuel García‐Pinilla(Centro de Investigación Biomédica en Red), Rachel Buchan(Guy's and St Thomas' NHS Foundation Trust), Erica Mazaika(Royal Brompton & Harefield NHS Foundation Trust), Upasana Tayal(University of Leeds), Richard Aplenc(Children's Hospital of Philadelphia), Anjali Owens(University of Pennsylvania), Ida G. Lunde(Oslo University Hospital), William Midwinter(Royal Brompton & Harefield NHS Foundation Trust), Fernándo Domínguez(Hospital Universitario Puerta de Hierro Majadahonda), Amanda M. Smith(University of Pennsylvania), Roddy Walsh(St George's, University of London), Hiroko Wakimoto(Brigham and Women's Hospital), Beatriz Núñez(Hospital Universitario Puerta de Hierro Majadahonda), Steven R. DePalma(Harvard University), Alexander R. Lyon(Royal Brompton Hospital), Sanjay Prasad(Royal Brompton Hospital), Domingo A. Pascual‐Figal(Spanish National Centre for Cardiovascular Research), Declan P. O’Regan(MRC London Institute of Medical Sciences), Stuart D. Rosen(Royal Brompton & Harefield NHS Foundation Trust), Stuart A. Cook(Hammersmith Hospital), Antonio de Marvao(St Thomas' Hospital), Kelly Getz(University of Pennsylvania), Jon A. L. Willcox(Harvard University), Christopher N. Toepfer(John Radcliffe Hospital), Enrique Lara‐Pezzi(Spanish National Centre for Cardiovascular Research), Brian S. Finkelman(University of Pennsylvania), Nicola Whiffin(Broad Institute), Mariano Provencio(Hospital Universitario Puerta de Hierro Majadahonda), María Alejandra Restrepo-Córdoba(Instituto de Salud Carlos III), Jian Li(National Clinical Research), Yuri Kim(Brigham and Women's Hospital), Kaoru Ito(RIKEN Center for Integrative Medical Sciences), Isabel Serrano(Institut de Recerca Biomèdica Catalunya Sud), Antonis Pantazis(Harefield Hospital), Luis Alonso‐Pulpón(Hospital Universitario Puerta de Hierro Majadahonda), Nathan Ingold(Royal Brompton & Harefield NHS Foundation Trust), Mian Ahmad(Royal Brompton & Harefield NHS Foundation Trust), Joshua Gorham(Harvard University)
Cited by 346
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k